Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMTRICITABINE Cause No adverse event? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of No adverse event have been filed in association with EMTRICITABINE (Truvada). This represents 0.3% of all adverse event reports for EMTRICITABINE.

11
Reports of No adverse event with EMTRICITABINE
0.3%
of all EMTRICITABINE reports
0
Deaths
0
Hospitalizations

How Dangerous Is No adverse event From EMTRICITABINE?

Of the 11 reports.

Is No adverse event Listed in the Official Label?

Yes, No adverse event is listed as a known adverse reaction in the official FDA drug label for EMTRICITABINE.

What Other Side Effects Does EMTRICITABINE Cause?

Foetal exposure during pregnancy (609) Drug resistance (370) Virologic failure (331) Immune reconstitution inflammatory syndrome (262) Exposure during pregnancy (212) Drug ineffective (196) Pathogen resistance (166) Viral mutation identified (161) Maternal exposure during pregnancy (160) Death (154)

What Other Drugs Cause No adverse event?

OMALIZUMAB (9,736) ALBUTEROL (8,971) ETONOGESTREL (8,827) TOCILIZUMAB (6,492) RITUXIMAB (5,915) METHYLPHENIDATE (4,197) MOMETASONE FUROATE (3,717) HUMAN IMMUNOGLOBULIN G (3,064) ETHINYL ESTRADIOL\NORELGESTROMIN (3,014) VEDOLIZUMAB (2,477)

Which EMTRICITABINE Alternatives Have Lower No adverse event Risk?

EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMTRICITABINE vs EMTRICITABINE\TENOFOVIR EMTRICITABINE vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE EMTRICITABINE vs EMTRICITABINE/TENOFOVIR DISOPROXIL

Related Pages

EMTRICITABINE Full Profile All No adverse event Reports All Drugs Causing No adverse event EMTRICITABINE Demographics